DexCom (DXCM) Business News

Track DexCom in real time with a live news feed covering DexCom stock news, official press releases, company announcements, and an archive of historical DexCom news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
2:30 AM | Thursday | Nov 19, 2026 Business Wire

Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone

News Thumbnail
2:30 AM | Thursday | Nov 19, 2026 Business Wire

Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone

News Thumbnail
9:00 AM | Tuesday | Nov 10, 2026 Business Wire

Dexcom Announces Upcoming Conference Presentation

News Thumbnail
8:00 AM | Monday | Nov 2, 2026 Business Wire

Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign

News Thumbnail
4:03 PM | Thursday | Oct 29, 2026 Business Wire

Dexcom Reports Third Quarter 2026 Financial Results

News Thumbnail
8:00 AM | Wednesday | Oct 28, 2026 Business Wire

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

News Thumbnail
3:29 PM | Tuesday | Oct 27, 2026 PRNewsWire

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

News Thumbnail
5:10 PM | Wednesday | Oct 14, 2026 Business Wire

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

News Thumbnail
9:00 AM | Tuesday | Oct 6, 2026 Business Wire

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

News Thumbnail
2:00 AM | Monday | Sep 28, 2026 Business Wire

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

News Thumbnail
4:30 PM | Monday | Sep 14, 2026 Business Wire

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

News Thumbnail
news photo
Loading...

ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry, County Galway, marking a major milestone in the company's investment in Ireland and its manufacturing presence in Europe, the Middle East and Africa. The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Mi.

Read full article redirect
2:30 AM | Thursday | Nov 19, 2026

Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone

Business Wire

ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry, County Galway, marking a major milestone in the company's investment in Ireland and its manufacturing presence in Europe, the Middle East and Africa. The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Mi.

Read full article arrow
News Thumbnail
2:30 AM | Thursday | Nov 19, 2026

Dexcom Marks Athenry Opening With Celebration of Commercial Production Milestone

Business Wire

ATHENRY, Ireland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art manufacturing facility in Athenry, County Galway, marking a major milestone in the company's investment in Ireland and its manufacturing presence in Europe, the Middle East and Africa. The official opening ceremony, attended by Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation, Jack Chambers, TD; Mi.

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Nov 10, 2026

Dexcom Announces Upcoming Conference Presentation

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026.The live presentation is scheduled to begin at approximately 2:00 PM GMT (9:00 AM EST) and will be concurrently webcast.Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.
com and will be archived there for future reference.About DexCom, Inc.

Read full article arrow
News Thumbnail
8:00 AM | Monday | Nov 2, 2026

Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today launched A Letter to Diabetes in honor of National Diabetes Awareness Month and World Diabetes Day, creating a platform for people around the world to put into words everything they've wanted to say about their diabetes journey, from the heartfelt and humorous to the hopeful and unexpected.Throughout November, anyone touched by diabetes is invited to share their own letter to diabetes, includi.

Read full article arrow
News Thumbnail
4:03 PM | Thursday | Oct 29, 2026

Dexcom Reports Third Quarter 2026 Financial Results

Business Wire

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Third Quarter 2026 Financial Results.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Oct 28, 2026

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

Business Wire

BURNABY, British Columbia--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) will be available in Canada beginning next month for adults 18 years and older living with diabetes. Offering up to 15.5 days of wear,2 Dexcom G7 15 Day combines industry leading sensor duration with best-in-class accuracy,1 giving Canadians living with diabetes more time between sensor changes and.

Read full article arrow
News Thumbnail
3:29 PM | Tuesday | Oct 27, 2026

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Read full article arrow
News Thumbnail
5:10 PM | Wednesday | Oct 14, 2026

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced that results from the landmark CONNECT randomized controlled trial have been published in The New England Journal of Medicine (NEJM), providing rigorous evidence of the significant benefits of continuous glucose monitoring (CGM) for adults with Type 2 diabetes not on insulin. CONNECT participants using Dexcom G7 experienced an average 1.6% A1C reduction from a mean baseline of 8.8%,.

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Oct 6, 2026

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DEXCOM, INC. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fifth season of Dexcom U, the company's one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.Now in its fifth year, this marks the program's largest and most expansive roster to date, featuring 27 college athletes, 12 new and 15 returning, across 13 sports. The expansion is backed by new research showing that programs l.

Read full article arrow
News Thumbnail
2:00 AM | Monday | Sep 28, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Business Wire

MILAN--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its “Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology” in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk.
Dexcom releases 2026 edition of its State of Type 2 Repo.

Read full article arrow
News Thumbnail
4:30 PM | Monday | Sep 14, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

Business Wire

SAN DIEGO--(BUSINESS WIRE)--Dexcom Promotes Jereme Sylvain to Chief Operating Officer.

Read full article arrow
News Thumbnail